| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.066 | 0.2 |